Connecticut officials announced that the state will receive about $8 million as part of a multi-state settlement with the drug company that makes Suboxone.
Federal prosecutors say the drug company Indivior pleaded guilty last year to criminal charges for wrongfully promoting Suboxone to treat opioid addiction.
The drug contains buprenorphine, a powerful and addictive opioid.
They said the company’s misconduct also allowed them improper Medicaid expenditures.
The settlement is up to $300 million, where $204 million will go to Medicaid, and about $91 million will be distributed to the 50 states.
State Attorney General William Tong said in a statement that this settlement sends a strong message in taking “aggressive action against those who fraudulently and callously contributed to the opioid epidemic.”